Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00031902
Status:
UNKNOWN
Last Update Posted:
2013-09-20
First Post:
2002-03-08
Brief Title:
Rituximab Plus Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkins Lymphoma
Sponsor:
Lymphoma Trials Office
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000069238
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lymphoma Trials Office
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None